Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

[How to treat systemic necrotizing vasculitides?].

Guillevin L.

Presse Med. 2012 Oct;41(10):1024-30. doi: 10.1016/j.lpm.2012.06.008. Epub 2012 Aug 18. Review. French.

PMID:
22906773
2.

[Treatment of ANCA-associated vascularitides].

Guillevin L, Pagnoux C.

Presse Med. 2007 May;36(5 Pt 2):922-7. Epub 2007 Apr 3. Review. French.

PMID:
17408912
3.

Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.

Pagnoux C, Quéméneur T, Ninet J, Diot E, Kyndt X, de Wazières B, Reny JL, Puéchal X, le Berruyer PY, Lidove O, Vanhille P, Godmer P, Fain O, Blockmans D, Bienvenu B, Rollot F, Aït el Ghaz-Poignant S, Mahr A, Cohen P, Mouthon L, Perrodeau E, Ravaud P, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2015 Apr;67(4):1117-27. doi: 10.1002/art.39011.

4.

[Treatment of systemic vasculitides].

Guillevin L, Pagnoux C.

Rev Prat. 2008 Mar 15;58(5):541-4. Review. French.

PMID:
18524111
5.

Therapeutic strategies for systemic necrotizing vasculitides.

Guillevin L, Pagnoux C.

Allergol Int. 2007 Jun;56(2):105-11. Epub 2007 May 1. Review.

6.

Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.

Lynch JP 3rd, Tazelaar H.

Semin Respir Crit Care Med. 2011 Jun;32(3):274-97. doi: 10.1055/s-0031-1279825. Epub 2011 Jun 14.

PMID:
21674414
7.

Treatment of primary systemic necrotizing vasculitides: the role of biotherapies.

Guillevin L.

Clin Exp Nephrol. 2013 Oct;17(5):622-7. doi: 10.1007/s10157-013-0860-2. Epub 2013 Sep 10. Review.

PMID:
24018402
8.

Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.

[No authors listed]

Prescrire Int. 2015 Jun;24(161):145-8. Review.

PMID:
26436161
9.

[Microscopic polyangiitis].

Pagnoux C, Guilpain P, Guillevin L.

Presse Med. 2007 May;36(5 Pt 2):895-901. Epub 2007 Mar 12. Review. French.

PMID:
17350793
10.

Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.

Semple D, Keogh J, Forni L, Venn R.

Crit Care. 2005 Apr;9(2):193-7. Epub 2004 Aug 18. Review.

11.

Therapeutic immunomodulation in systemic vasculitis: taking stock.

Puéchal X, Guillevin L.

Joint Bone Spine. 2013 Jul;80(4):374-9. doi: 10.1016/j.jbspin.2012.10.023. Epub 2012 Dec 11. Review.

PMID:
23237994
12.

[Treatment with rituximab for a patient with p-ANCA glomerulonephritis, alveolar bleeding and multiple relapses during haemodialysis].

Azancot MA, Agraz Pamplona I, Fort Ros J, Marín Valencia A, Gil Carballeira I, Camps Domenech J.

Nefrologia. 2010;30(6):710-2. doi: 10.3265/Nefrologia.pre2010.Aug.10535. Spanish. No abstract available.

13.

Rituximab for ANCA-associated vasculitides.

Guillevin L.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S118-21. Epub 2014 May 16. Review.

PMID:
24854382
14.

Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis.

Dhaygude A, Griffith M, Cairns T, McLean A, Palmer A, Taube D.

Nephron Clin Pract. 2004;97(4):c154-9. Review.

PMID:
15331939
15.

Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.

Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Baldovino S, Menegatti E, La Grotta R, Modena V.

Nephrol Dial Transplant. 2011 Dec;26(12):3987-92. doi: 10.1093/ndt/gfr109. Epub 2011 Mar 8.

16.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH; RAVE-ITN Research Group.

N Engl J Med. 2013 Aug 1;369(5):417-27. doi: 10.1056/NEJMoa1213277.

17.

[Treatment of Wegener's granulomatosis].

Riccieri V, Valesini G.

Reumatismo. 2004 Apr-Jun;56(2):69-76. Review. Italian.

18.

[Churg-Strauss syndrome].

Lhote F.

Presse Med. 2007 May;36(5 Pt 2):875-89. Epub 2007 Apr 3. Review. French.

PMID:
17408916
19.

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.

Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quémeneur T, Blanchard-Delaunay C, Godmer P, Puéchal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L; French Vasculitis Study Group.

N Engl J Med. 2014 Nov 6;371(19):1771-80. doi: 10.1056/NEJMoa1404231.

20.

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.

Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR; European Vasculitis Society (EUVAS).

Ann Rheum Dis. 2015 Jun;74(6):1178-82. doi: 10.1136/annrheumdis-2014-206404. Epub 2015 Mar 4.

PMID:
25739829

Supplemental Content

Support Center